Vietnam to Host the 3rd International Forum of Pharmaceutical Inspectorates
16–17 November 2026 in Hanoi, Vietnam.
This annual IFPI Forum is recognized as a landmark occasion for the global GMP community. The Forum will bring together heads of national regulatory authorities, GMP experts, and pharmaceutical industry representatives worldwide.
The event aims to accelerate regulatory harmonization and improve patient access to innovative medicines.
This year, the Forum will place a particular focus on the implementation of Good Regulatory Practice (GRP), which serves as a foundation for strengthening national regulatory capacity and harmonizing pharmaceutical requirements in line with international standards.
“Regulatory reliance is increasingly becoming a strategic asset that enables countries not only to take a leading role in shaping the global health security architecture, but also to expand and accelerate patient access to innovative, life-saving medicines on global markets.
This Forum offers a unique opportunity to engage with regulatory authorities from around the world in discussing the challenges nations face when transitioning to Good Regulatory Practices (GRP), as well as exploring ways to streamline this process”.
Dr. Taruna Ikrar,
Chairperson of the Indonesian Food and Drug Authority
Regulatory convergence, enhanced cooperation in GMP inspections, fostering open dialogue, and strengthening mutual reliance — these are the fundamental principles that underpin the very concept of IFPI.
“As representatives of the Uruguayan health authority, we have been participating in the International Pharmaceutical Inspection Forum. In our experience, it has been clearly demonstrated that the Forum is an exceptional platform for exchanging best practices, conducting thorough analysis, and subsequently integrating them. Practical dialogue is especially relevant in the face of challenges such as the emergence of advanced therapy medicinal products, which require rapid adaptation of regulatory frameworks. We look forward to meeting with our colleagues in Vietnam, convinced that only through joint efforts we be able to developed solutions to the systemic challenges facing the Good Manufacturing Practice (GMP) professional community.”
Q.F. Cecilia Martinez
Director, Inspection Division, General Directorate of Inspection, Ministry of Public Health of Uruguay
The following key topics will be in the spotlight at the Forum this year:
– Challenges in implementing Good Regulatory Practice;
– Specific aspects of regulation and manufacture of advanced therapy medicinal products, blood products, and radiopharmaceuticals;
– Reducing administrative barriers and costs associated with market access for pharmaceutical products.
The two-day event will include a Plenary Session, Expert Panels, workshops and presentations of year-long activities by IFPI Working Groups. It will also feature an exhibition of advanced pharmaceutical products.